Viewing Study NCT02001064



Ignite Creation Date: 2024-05-06 @ 2:17 AM
Last Modification Date: 2024-10-26 @ 11:15 AM
Study NCT ID: NCT02001064
Status: COMPLETED
Last Update Posted: 2021-07-29
First Post: 2013-11-27

Brief Title: Care4Today v20 Application for Improving Adherence to HIV Medications
Sponsor: University of California San Diego
Organization: University of California San Diego

Study Overview

Official Title: Pilot Study of Care4Today v20 Application for Improving Adherence to HIV Medications
Status: COMPLETED
Status Verified Date: 2021-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Although poor antiretroviral ART adherence in HIV does not mean a complete lack of therapeutic results the benefit of ART increases as adherence improves Consequences of suboptimal ART adherence are viral rebound development of drug-resistant HIV strains and more rapid progression to AIDS Moreover HIV-infected persons tend to have numerous co-occurring conditions and therefore take many medications making adherence to multiple drug regimens more difficult A mobile application capable of improving medication adherence among HIV-infected persons would be highly useful

The investigators propose an intervention study designed to address these potential mechanisms of nonadherence by utilizing the Care4Today v20 smartphone application app The current study is a small pilot Randomized Controlled Trial RCT comparing the smart phone application titled Care4Today v20 versus standard of care to improve medication adherence to ART over a 4-week period with 60 HIV-infected participants

The pilot RCT consists of 60 HIV-infected persons who are at risk for ART medication nonadherence Using random assignment 30 HIV-infected participants will be assigned to medication adherence improvement via Care4Today app as compared to 30 HIV-infected participants assigned standard of care

The investigators will assess the effectiveness and acceptability of the app in improving objectively measured ART adherence ie via medication event monitoring system caps over a 4-week period via a pilot RCT with 30 HIV-infected persons assigned to the Care4Today intervention and 30 HIV-infected persons assigned to standard of care
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None